Point72 (Difc) LTD Cassava Sciences Inc Transaction History
Point72 (Difc) LTD
- $2.72 Trillion
- Q4 2024
A detailed history of Point72 (Difc) LTD transactions in Cassava Sciences Inc stock. As of the latest transaction made, Point72 (Difc) LTD holds 47,173 shares of SAVA stock, worth $114,158. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,173Holding current value
$114,158% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SAVA
# of Institutions
189Shares Held
16MCall Options Held
3.7MPut Options Held
8.77M-
Black Rock Inc. New York, NY3.22MShares$7.79 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.51MShares$6.08 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.01MShares$2.44 Million0.0% of portfolio
-
State Street Corp Boston, MA997KShares$2.41 Million0.0% of portfolio
-
Ubs Group Ag931KShares$2.25 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $97M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...